Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Comment
  • Published:

Towards the taxonomy of human disease

Nature Reviews Drug Discovery volume 14, pages 75–76 (2015)Cite this article

Subjects

Abstract

Consortia have begun to establish 'mechanism-based taxonomies' for inflammatory and neurodegenerative diseases that could aid drug development and personalized therapy.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Kola, I. & Bell. J. A call to reform the taxonomy of human disease. Nature Rev. Drug Discov. 10, 641–642 (2011).

    Article  CAS  Google Scholar 

  2. Mok, T. S. et al. Gefitinib or carboplatin–paclitaxel in pulmonary adenocarcinoma. N. Engl. J. Med. 361, 947–957 (2009).

    Article  CAS  Google Scholar 

  3. Chapman, P. B. et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N. Engl. J. Med. 364, 2507–2516 (2011).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Bioinformatics, Fraunhofer Institute for Algorithms and Scientific Computing (SCAI) Schloss Birlinghoven, Sankt Augustin, D-53754, Germany

    Martin Hofmann-Apitius

  2. GENYO. Centro de Genómica e Investigación Oncológica Pfizer–Universidad de Granada-Junta de Andalucía, PTS Granada, Granada, 18016, Spain

    Marta E. Alarcón-Riquelme

  3. New Medicines, UCB, 208 Bath Road, Slough, SL1 4EN, UK

    Chris Chamberlain & Duncan McHale

Authors
  1. Martin Hofmann-Apitius
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marta E. Alarcón-Riquelme
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chris Chamberlain
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Duncan McHale
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Duncan McHale.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Related links

Related links

FURTHER INFORMATION

Innovative Medicines Initiative

PRECISESADS

AETIONOMY

tranSMART Foundation

The Systems Biology Markup Language (SMBL)

Biological Expression Language (OpenBEL)

Resource Description Framework (RDF)

ApiNATOMY

European Prevention of Alzheimer's Dementia (EPAD) Consortium

Global Alzheimer's Platform (GAP)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hofmann-Apitius, M., Alarcón-Riquelme, M., Chamberlain, C. et al. Towards the taxonomy of human disease. Nat Rev Drug Discov 14, 75–76 (2015). https://doi.org/10.1038/nrd4537

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd4537

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research